Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verification.
about
Data-driven risk identification in phase III clinical trials using central statistical monitoring.The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature.Taking the 'Risk' out of risk-based monitoring.Evolving quality standards for large-scale registries: the GARFIELD-AF experience.Exploring Data Quality Management within Clinical Trials.
P2860
Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verification.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hybrid approaches to clinical ...... 100% source data verification.
@ast
Hybrid approaches to clinical ...... 100% source data verification.
@en
Hybrid approaches to clinical ...... 100% source data verification.
@nl
type
label
Hybrid approaches to clinical ...... 100% source data verification.
@ast
Hybrid approaches to clinical ...... 100% source data verification.
@en
Hybrid approaches to clinical ...... 100% source data verification.
@nl
prefLabel
Hybrid approaches to clinical ...... 100% source data verification.
@ast
Hybrid approaches to clinical ...... 100% source data verification.
@en
Hybrid approaches to clinical ...... 100% source data verification.
@nl
P356
P1476
Hybrid approaches to clinical ...... 100% source data verification.
@en
P2093
Sourabh De
P2860
P304
P356
10.4103/2229-3485.83226
P577
2011-07-01T00:00:00Z